yellow-fever

Documents about yellow-fever

• Trial of Yellow Fever Inactivated Vaccine#307303ClinicalTrials.gov
• Human Immune Responses to Yellow Fever Vaccination#1009756ClinicalTrials.gov
• Eliminate yellow fever epidemics (EYE) strategy country toolkit#129095WHO IRIS
• Booster Vaccine for Yellow Fever#377270ClinicalTrials.gov
• Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine#387195ClinicalTrials.gov
• Immunity After Two Doses of Yellow Fever Vaccine#872424ClinicalTrials.gov
• Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil.#672463REPOSITORIO INSTITUCIONAL DA UFOP
• WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever#129089WHO IRIS
• Angel Agnes The Heroine of the Yellow Fever Plague in Shreveport#39013Project Gutenberg
• Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults#829551ClinicalTrials.gov
• CDC MAC ELISA caculations workbook#279015WHO IRIS
• Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans#683125ClinicalTrials.gov
• Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults#895615ClinicalTrials.gov
• Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia#883846ClinicalTrials.gov
• Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine#910764ClinicalTrials.gov
• A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers#226332ClinicalTrials.gov
• Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA#861141ClinicalTrials.gov
• Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination#262275HAL (France)
• The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination#839512ClinicalTrials.gov
• Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old#272425ClinicalTrials.gov
• Yellow fever outbreak in Angola incident management: situation report 15 May 2016#129059WHO IRIS
• Why Yellow Fever Isn't Flattering: A Case Against Racial Fetishes#763493PhilArchive
• A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults#180225ClinicalTrials.gov
• Characterization of the first complete genome sequence of yellow fever virus (YFV) in Sierra Leone: Implications for public health#197010PLOS
• The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.#982515ClinicalTrials.gov
• Urban yellow fever risk management: handbook for national preparedness and response planning#627351World Health Organization
• Genomic epidemiology unveils the dynamics and spatial corridor behind the Yellow Fever virus outbreak in Southern Brazil#336521SUNScholar
• The Senator's Bride#56037Project Gutenberg
• Root cause analysis of low yellow fever vaccination coverage: user manual and questionnaire#373063World Health Organization
• A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population#261358ClinicalTrials.gov
• Data and code from "The overlapping global distribution of dengue, chikungunya, Zika and yellow fever"#274976LSHTM Data Compass
• Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis#451506ClinicalTrials.gov
• Fine-grained spatial data-driven ensemble modeling for predicting Sylvatic Yellow Fever environmental suitability in Brazil#146513bioRxiv / medRxiv
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults#885194ClinicalTrials.gov
• Evolution and spillover dynamics of yellow fever at the forest-urban interface in Brazil#5730Europe PMC
• The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans#383613ClinicalTrials.gov
• Fine-grained spatial data-driven ensemble modeling for predicting Sylvatic Yellow Fever environmental suitability in Brazil#149874Unpaywall
• Soft Selective Sweeps Predominate in the Yellow Fever Mosquito Aedes aegypti#5728Europe PMC
• Multiple, but not isolated, yellow fever virus-associated orthoflavivirus immune histories drive antibody-dependent enhancement of Zika and dengue viruses#369720bioRxiv / medRxiv
• From vaccine availability to effective deployment: Closing the arboviral vaccine access gap#784660Europe PMC
• NOTIFICATIONS of plague, cholera, yellow fever, smallpox, typhus and relapsing fever under International Sanitary Legislation = NOTIFICATIONS de peste, choléra, fièvre jaune, variole, typhus et fièvre récurrente, aux termes de la législation sanitaire internationale#649913WHO IRIS
• Arthur Mervyn; Or, Memoirs of the Year 1793#39519Project Gutenberg
• Epidemiological, entomological and community determinants of the 2021 yellow fever outbreak in Wa East District, Ghana: cross-sectional descriptive outbreak investigation.#138603NCBI PubMed Central
• L'epidémie de fièvre jaune au Burkina Faso en 1983#163836WHO IRIS
• Chita: A Memory of Last Island#24959Project Gutenberg
• Yellow fever outbreak temporarily changes dispersal patterns in an endangered primate#68407HAL (France)
• Yellow fever virus infection in non-human primates: a systematic review and meta-analysis of prevalence, seroprevalence, and epizootic case reports (1950–2025).#18508NCBI PubMed Central
• Yellow Fever, an Arboviral Disease with Public Health Impacts: General Aspects and the Use of the One Health Approach in the Context of This Zoonosis.#671316NCBI PubMed Central
• Yellow Fever Vaccination in an Individual with Confirmed Egg Protein Allergy: A Case Report / Nelly Otte, Amir Maleki Kahaki, Gerda Wurpts, Thomas Kraus, Julia Krabbe#780339Deutsche Nationalbibliothek
• In vivo risk assessment of yellow fever virus transmission through breastfeeding, and mechanistic insights#395307HAL (France)